PHARMING GRP SP. ADRS Price, Chart & Factor Analysis
Free Data & Analytics AccessPHARMING GRP SP. ADRS Forecast
PHARMING GRP SP. ADRS short-term momentum is neutral (up over 2 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term NEUTRAL signal. The long-term trend is neutral (4 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term NEUTRAL signal. Based on 20-day realised volatility of 42.0% a year, a typical one-standard-deviation range is 10.04–11.30 over a week, 9.3774–11.96 over a month and 6.1923–15.15 over a year. (Signals as of 22 Nov 2026.)
PHARMING GRP SP. ADRS Price Chart
PHARMING GRP SP. ADRS Factors
Research on PHARMING GRP SP. ADRS
Explore MacroFinance macro & markets research and analysis.
PHARMING GRP SP. ADRS Trading Strategies
9 backtested tactical asset allocation strategies hold VGK (European market), the closest tradable exposure to PHARMING GRP SP. ADRS; 1 of them are invested now. Strategies currently invested are listed first.
| Strategy | Style | Rebalance | Now in VGK | CAGR | Sharpe | Max DD |
|---|---|---|---|---|---|---|
| Adaptive Asset Allocation | Moderate | Monthly | Premium · upgrade to view | |||
| Keller and Keuning's Defensive Asset Allocation | Moderate | Monthly | Premium · upgrade to view | |||
| Keller and Keuning's Protective Asset Allocation - CPR | Moderate | Monthly | Premium · upgrade to view | |||
| Financial Mentor's Optimum3 | Moderate | Monthly | Premium · upgrade to view | |||
| Wouter Keller's Bold Asset Allocation - Balanced | Moderate | Monthly | Premium · upgrade to view | |||
| Keller and Keuning's Protective Asset Allocation | Moderate | Monthly | Premium · upgrade to view | |||
| Keller and Keuning's Vigilant Asset Allocation - Balanced | Moderate | Monthly | Premium · upgrade to view | |||
| Ilya Kipnis' Defensive Adaptive Asset Allocation | Moderate | Monthly | Premium · upgrade to view | |||
| Keuning and Keller's Generalized Protective Momentum | Moderate | Monthly | Premium · upgrade to view | |||
Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.
Statistical Distribution of Returns
PlusHow PHARMING GRP SP. ADRS’s returns are distributed — and how they change in a given market regime.
Regime filters
| Market/Macro | Indicator | Criteria | Value | And (for Between) | Action |
|---|
No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.
| Statistic | All periods | Matching |
|---|
About PHARMING GRP SP. ADRS (Germany)
PHARMING GRP SP. ADRS is a listed security in Germany. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).
Last updated: November 22, 2026
More on Koninklijke Philips NV ADR
Frequently asked questions
What is PHARMING GRP SP. ADRS?
What is the latest PHARMING GRP SP. ADRS price?
Is PHARMING GRP SP. ADRS in an uptrend?
How volatile is PHARMING GRP SP. ADRS?
What factors affect PHARMING GRP SP. ADRS?
Which trading strategies trade PHARMING GRP SP. ADRS?
How are PHARMING GRP SP. ADRS returns analysed?
Where can I download free PHARMING GRP SP. ADRS historical data?
Free PHARMING GRP SP. ADRS historical data (last 10 years)
Browse or instantly download the last 10 years of PHARMING GRP SP. ADRS daily price history. A free account unlocks the full history, an Excel export with factors, and API access.
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.PHG.F&format=csv&years=10
| Date | Close |
|---|---|
| 2026-11-20 | 10.67 |
| 2026-11-19 | 10.873 |
| 2026-11-18 | 10.931 |
| 2026-11-17 | 10.976 |
| 2026-11-16 | 11.104 |
| 2026-11-13 | 11.185 |
| 2026-11-12 | 11.426 |
| 2026-11-11 | 11.275 |
| 2026-11-10 | 11.199 |
| 2026-11-09 | 11.091 |
About this stock
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3Kd inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3Kd inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
See how this market's returns behaved when a factor was in a given state, for example when Momentum was strong or bond yields were above 4%, and compare that with all periods.
Reading the chart
- Each bar is a return bucket; its height is the share of periods that landed there.
- All periods: every return in the date range.
- Matching periods: only the periods where all your filters were true. If orange shifts right of the grey, returns were better in that regime.
- Each period's return is the return over the following day, week or month (set by Timeframe), measured from the day the factor was read, so there is no look-ahead.
Adding a filter
- Factor: grouped the same way as the Factors section on this page (Quantitative, Country, Sector, …). Locked factors are listed but greyed out.
- Criteria: greater (>), greater or equal (≥), equal (=), smaller or equal (≤), smaller (<) or between two values.
- Value: depends on the factor.
- Momentum and Trend are signals from −1 to +1, picked as −100 to +100 in steps of 25.
- Mean Reversion is a z-score of price against its 250-day mean, picked in σ from −3 to +3.
- Everything else is a number you type. The line under the box shows the latest reading and its typical range over the last 10 years.
Add several filters to combine conditions; a period must pass every one. Narrow the window with the From/To dates or the 1Y / 5Y / 10Y / MAX buttons; Clear resets filters and dates.
Return statistics
- Unfiltered vs Filtered: all periods vs matching periods.
- Average return, Std dev and Sharpe are annualised (252 days, 52 weeks, 12 months, 6 two-month periods, 4 quarters).
- Maximum drawdown compounds non-overlapping periods; in the Filtered column it assumes you held only while the condition was true.
- Min, 25th percentile, median, 75th percentile and max are per period, not annualised.